会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 49. 发明授权
    • Tricyclic imidazole compounds as PDE10 inhibitors
    • 三环咪唑化合物作为PDE10抑制剂
    • US08552045B2
    • 2013-10-08
    • US13299368
    • 2011-11-18
    • Jan KehlerJacob NielsenMauro MarigoJohn Paul KilburnMorten Langgård
    • Jan KehlerJacob NielsenMauro MarigoJohn Paul KilburnMorten Langgård
    • A61K31/415
    • C07D487/04A61K31/437A61K31/4985A61K45/06C07D471/04C07D519/00
    • This invention is directed to compounds with the structure which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula 1. The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula 1. The present invention also provides a method of treating a subject suffering from a drug addiction comprising administering to the subject a therapeutically effective amount of a compound of formula 1. The present invention further provides a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula 1.
    • 本发明涉及具有PDE10A酶抑制剂结构的化合物。 本发明提供了包含治疗有效量的本发明化合物和药学上可接受的载体的药物组合物。 本发明还提供了制备式1化合物的方法。本发明还提供了治疗患有神经变性疾病的受试者的方法,其包括向受试者施用治疗有效量的式1的化合物。本发明 本发明还提供了治疗患有药物成瘾的受试者的方法,包括向受试者施用治疗有效量的式1化合物。本发明还提供了治疗患有精神障碍的受试者的方法,包括给予 服用治疗有效量的式1化合物。
    • 50. 发明授权
    • (2-aryl-1H-imidazol-4-yl)-linked heterocycle derivatives
    • (2-芳基-1H-咪唑-4-基) - 连接的杂环衍生物
    • US08501797B2
    • 2013-08-06
    • US13515325
    • 2010-12-15
    • Ask PüschlJacob NielsenJan KehlerJohn Paul KilburnMauro MarigoMorten Langgård
    • Ask PüschlJacob NielsenJan KehlerJohn Paul KilburnMauro MarigoMorten Langgård
    • A61K31/415
    • C07D487/04C07D471/04
    • This invention is directed to compounds of formula I having the structure which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula I. The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I The present invention also provides a method of treating a subject suffering from a drug addiction comprising administering to the subject a therapeutically effective amount of a compound of formula I. The present invention further provides a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I.
    • 本发明涉及具有PDE10A酶抑制剂结构的式I化合物。 本发明提供了包含治疗有效量的本发明化合物和药学上可接受的载体的药物组合物。 本发明还提供了制备式I化合物的方法。本发明还提供了治疗患有神经退行性疾病的受试者的方法,包括给予受试者治疗有效量的式I化合物本发明 还提供了治疗患有药物成瘾的受试者的方法,包括向受试者施用治疗有效量的式I化合物。本发明还提供治疗患有精神障碍的受试者的方法,其包括向受试者施用 治疗有效量的式I化合物。